Jacobs Levy Equity Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.64M | Buy |
+148,201
| New | +$2.64M | 0.01% | 566 |
|
|
2024
Q2 | – | Sell |
-475,226
| Closed | -$7.43M | – | 1018 |
|
|
2024
Q1 | $7.43M | Buy |
475,226
+358,062
| +306% | +$5.6M | 0.03% | 356 |
|
|
2023
Q4 | $1.75M | Buy |
117,164
+95,202
| +433% | +$1.42M | 0.01% | 619 |
|
|
2023
Q3 | $355K | Buy |
+21,962
| New | +$355K | ﹤0.01% | 860 |
|
|
2021
Q2 | – | Sell |
-209,211
| Closed | -$27.7M | – | 1090 |
|
|
2021
Q1 | $27.7M | Buy |
209,211
+27,209
| +15% | +$3.6M | 0.21% | 126 |
|
|
2020
Q4 | $31.5M | Buy |
182,002
+105,892
| +139% | +$18.3M | 0.28% | 93 |
|
|
2020
Q3 | $8.47M | Sell |
76,110
-9,990
| -12% | -$1.11M | 0.09% | 242 |
|
|
2020
Q2 | $5.11M | Buy |
86,100
+37,245
| +76% | +$2.21M | 0.06% | 328 |
|
|
2020
Q1 | $3.29M | Sell |
48,855
-1,035
| -2% | -$69.7K | 0.04% | 373 |
|
|
2019
Q4 | $4.2M | Sell |
49,890
-36,443
| -42% | -$3.07M | 0.04% | 408 |
|
|
2019
Q3 | $6.46M | Sell |
86,333
-19,290
| -18% | -$1.44M | 0.08% | 293 |
|
|
2019
Q2 | $6.68M | Buy |
105,623
+190
| +0.2% | +$12K | 0.09% | 278 |
|
|
2019
Q1 | $5.08M | Buy |
105,433
+17,970
| +21% | +$866K | 0.07% | 328 |
|
|
2018
Q4 | $2.93M | Buy |
87,463
+4,364
| +5% | +$146K | 0.05% | 373 |
|
|
2018
Q3 | $4.35M | Buy |
83,099
+44,569
| +116% | +$2.34M | 0.06% | 344 |
|
|
2018
Q2 | $1.21M | Buy |
+38,530
| New | +$1.21M | 0.02% | 616 |
|